arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

PMGC Holdings Inc.

ELAB
$0.92 ▼ -0.03 (-3.42%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
18 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
22
Health
Poor
Bearish
auto_awesome

Analytical Summary

PMGC Holdings Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth None
Op. Margin None
ROIC None
FCF / Share $-7.52
Trailing P/E
Price / Book 0.1x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$681.99K
↑ +124.2%
Net Income Profit after all expenses
$-4.97M
↓ -208.8%
Operating Margin Operating profit as % of sales
-174.4%
↑ +25.0%
FCF / Share Free cash flow per share
$-7.52
↓ -204.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
9
Cash Quality
56

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 5 years · 18 quarters